Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning (Q34567884)

3 August 2017

1 reference

title

Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

Michele Zell Kanter

1

1 reference

full work available at URL

3 August 2017

language of work or name

1 reference

2006

1 October 2006

0 references

https://academic.oup.com/ajhp/article-abstract/63/19/1821/5134471?redirectedFrom=fulltext

0 references

published in

American Journal of Health-System Pharmacy

1 reference

3 August 2017

volume

63

1 reference

3 August 2017

issue

19

1 reference

3 August 2017

page(s)

1821-1827

1 reference

Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation

3 August 2017

cites work

1 reference

Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo

31 March 2020

1 reference

Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans.

31 March 2020

1 reference

Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning

31 March 2020

1 reference

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

31 March 2020

1 reference

Oral or intravenous N-acetylcysteine for acetaminophen poisoning?

31 March 2020

1 reference

Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol

31 March 2020

1 reference

Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose

31 March 2020

1 reference

Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: Results of an open-label, clinical trial

31 March 2020

1 reference

Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?

31 March 2020

1 reference

2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

31 March 2020

1 reference

Dilution of Intravenous N-Acetylcysteine as a Cause of Hyponatremia

31 March 2020

1 reference

Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity

31 March 2020

1 reference

Adverse reactions to N-acetylcysteine

31 March 2020

1 reference

Adverse reactions to acetylcysteine and effects of overdose

31 March 2020

1 reference

The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine

31 March 2020

1 reference

What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?

31 March 2020

1 reference

Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning

31 March 2020

1 reference

31 March 2020

1 reference

Intravenous loading infusion rates of N-acetylcysteine

31 March 2020

1 reference

Management of anaphylactoid reactions to intravenous N-acetylcysteine

31 March 2020

1 reference

Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine

31 March 2020

1 reference

Acetaminophen inhibits the human polymorphonuclear leukocyte function in vitro

31 March 2020

1 reference

Inhibition of human platelet function in vitro and ex vivo by acetaminophen

31 March 2020

1 reference

Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases.

31 March 2020

1 reference

Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma

31 March 2020

1 reference

Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death

31 March 2020

1 reference

The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects

31 March 2020

1 reference

Intravenous administration of N-acetylcysteine: interference with coagulopathy testing

31 March 2020

1 reference

What is the rate of adverse events with intravenous versus oral N-acetylcysteine in pediatric patients?

31 March 2020

1 reference

Coagulation protein function. II. Influence of thiols upon acetaldehyde effects

31 March 2020

1 reference

Effect of paracetamol poisoning on international normalised ratio

31 March 2020

1 reference

Interaction between N-acetylcysteine and activated charcoal: implications for the treatment of acetaminophen poisoning

31 March 2020

1 reference

Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.2146/AJHP060050

1 reference

3 August 2017

0 references

1 reference